Innoviva, Inc. (INVA) vs Kestra Medical Technologies, Ltd. (KMTS)

A side-by-side comparison of Innoviva, Inc. and Kestra Medical Technologies, Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — INVA vs KMTS

growth of $100 · dividends reinvested · last 2y
INVA +17.2% (+8.3%/yr)KMTS +29.8% (+13.9%/yr)KMTS compounded faster over this window
80100120140Start $1002026$117$130
INVA KMTS

INVA vs KMTS: by the numbers

  • •KMTS is the larger company ($1.59B vs $1.54B market cap).
  • •INVA is profitable (80.56% net margin) while KMTS runs a net loss (-140.43%).

Metrics side by side

Valuation

MetricINVAKMTS
P/E ratio5.08N/A
Forward P/E8.61N/A
PEG ratio0.49N/A
P/S ratio3.4714.88
P/B ratio1.257.14
EV / EBITDA4.90N/A
FCF yield12.25%N/A

Profitability

MetricINVAKMTS
Gross margin73.09%53.89%
Operating margin36.66%-134.48%
Net margin80.56%-140.43%
ROE28.97%-67.40%
ROIC8.36%-47.99%

Growth (annualized)

MetricINVAKMTS
Revenue CAGR (5Y)3.94%N/A
EPS CAGR (5Y)12.71%N/A
FCF CAGR (5Y)-10.54%N/A
Total return CAGR (5Y)4.52%N/A

Frequently asked

Is INVA or KMTS more profitable?
INVA runs the higher net margin — INVA at 80.56% versus KMTS at -140.43%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.